Ixabepilone: A New Treatment Option for the Management of Taxane-Resistant Metastatic Breast Cancer

Cancer Management and Research - New Zealand
doi 10.2147/cmr.s5723
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

New Option for the Initial Management of Metastatic Pancreatic Cancer?

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Ixabepilone in Metastatic Breast Cancer: Complement or Alternative to Taxanes?

Clinical Cancer Research
Cancer ResearchOncology
2008English

Genomic Sequencing of Treatment-Resistant Metastatic Breast Cancer Reveals Key Alterations

Cancer
Cancer ResearchOncology
2017English

Choosing Treatment for Metastatic Breast Cancer.

BMJ
1982English

Vectors for Treatment of Metastatic Breast Cancer

2005English

Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

Evolving Approaches to Metastatic Breast Cancer Patients Pre-Treated With Anthracycline and Taxane

BioDrugs
MedicineBiotechnologyPharmacology
2013English

Symptom Management in Metastatic Breast Cancer

Oncologist
Cancer ResearchMedicineOncology
2011English

Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy